KBC Group NV Has $119,000 Position in iRhythm Technologies, Inc. (NASDAQ:IRTC)

KBC Group NV boosted its holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC) by 45.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,319 shares of the company’s stock after buying an additional 410 shares during the quarter. KBC Group NV’s holdings in iRhythm Technologies were worth $119,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Bank Pictet & Cie Europe AG raised its position in shares of iRhythm Technologies by 22.3% during the third quarter. Bank Pictet & Cie Europe AG now owns 3,105 shares of the company’s stock worth $231,000 after acquiring an additional 567 shares during the last quarter. Nisa Investment Advisors LLC raised its holdings in iRhythm Technologies by 166.6% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,037 shares of the company’s stock worth $94,000 after purchasing an additional 648 shares during the last quarter. Hennion & Walsh Asset Management Inc. lifted its position in shares of iRhythm Technologies by 27.3% in the 3rd quarter. Hennion & Walsh Asset Management Inc. now owns 3,512 shares of the company’s stock worth $261,000 after purchasing an additional 754 shares during the period. Quarry LP acquired a new position in shares of iRhythm Technologies in the 3rd quarter worth approximately $59,000. Finally, Assetmark Inc. boosted its stake in shares of iRhythm Technologies by 8.0% in the 3rd quarter. Assetmark Inc. now owns 12,645 shares of the company’s stock valued at $939,000 after purchasing an additional 937 shares during the last quarter.

iRhythm Technologies Trading Up 1.3 %

NASDAQ IRTC opened at $110.00 on Friday. The firm has a market capitalization of $3.44 billion, a P/E ratio of -22.63 and a beta of 1.29. The business has a fifty day simple moving average of $96.12 and a 200 day simple moving average of $81.81. iRhythm Technologies, Inc. has a 12 month low of $55.92 and a 12 month high of $124.11. The company has a current ratio of 6.27, a quick ratio of 6.12 and a debt-to-equity ratio of 9.00.

Analyst Upgrades and Downgrades

IRTC has been the topic of a number of recent analyst reports. Needham & Company LLC boosted their price objective on iRhythm Technologies from $96.00 to $112.00 and gave the company a “buy” rating in a research note on Monday, January 13th. Canaccord Genuity Group boosted their price target on iRhythm Technologies from $125.00 to $152.00 and gave the company a “buy” rating in a research note on Monday, December 9th. Robert W. Baird lowered their price objective on shares of iRhythm Technologies from $100.00 to $79.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Oppenheimer boosted their target price on shares of iRhythm Technologies from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Wednesday, January 8th. Finally, Truist Financial increased their target price on shares of iRhythm Technologies from $85.00 to $111.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $108.45.

Insider Activity at iRhythm Technologies

In related news, insider Patrick Michael Murphy sold 2,492 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $85.89, for a total transaction of $214,037.88. Following the completion of the sale, the insider now directly owns 35,327 shares of the company’s stock, valued at approximately $3,034,236.03. This trade represents a 6.59 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.68% of the stock is owned by insiders.

iRhythm Technologies Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.